Chemotherapy‑induced hypomethylation of N‑myc downstream‑regulated gene 4 in the bone marrow of patients with acute myeloid leukemia

  • Authors:
    • Qingxiao Hong
    • Xiaoying Chen
    • Huadan Ye
    • Xiaodong Wu
    • Xuejing Wang
    • Lingyan Kong
    • Yongming Xia
    • Shiwei Duan
  • View Affiliations

  • Published online on: March 10, 2017     https://doi.org/10.3892/ol.2017.5839
  • Pages: 3309-3313
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

N‑myc downstream‑regulated gene 4 (NDRG4) has previously been investigated as a possible tumor suppressor. Hypermethylation of tumor suppressor genes contributes to the occurrence and development of certain types of cancer, including acute myeloid leukemia (AML). The current study aimed to assess the contribution of chemotherapy‑induced NDRG4 changeable methylation to the development of AML. A total of 30 patients (13 males and 17 females) were involved in the present study. The DNA methylation levels of five C‑phosphate‑G sites of the NDRG4 gene were measured using bisulfite pyrosequencing techniques. The results indicated significantly reduced gene‑body methylation levels of NDRG4 during chemotherapy (prior to chemotherapy: 9.35±4.22%; following chemotherapy: 7.54±3.11%; P=0.030). Further analysis of AML subtypes revealed the methylation reductions were principally contributed by patients with M2 subtype AML (prior to chemotherapy: 9.91±4.76%; following chemotherapy: 5.26±1.16%; P=0.038). A significant association was also observed between the patient age and the altered levels of NDRG4 gene‑body methylation in patients with M2 subtype AML (r=0.761; P=0.047), suggesting that reductions in induced‑methylation may be age‑dependent in patients with M2 subtype AML during chemotherapy. Therefore, age may affect the induced methylation levels of NDRG4 gene‑body in patients with AML (particularly patients with M2 subtype AML) during chemotherapy.
View Figures
View References

Related Articles

Journal Cover

May-2017
Volume 13 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hong Q, Chen X, Ye H, Wu X, Wang X, Kong L, Xia Y and Duan S: Chemotherapy‑induced hypomethylation of N‑myc downstream‑regulated gene 4 in the bone marrow of patients with acute myeloid leukemia. Oncol Lett 13: 3309-3313, 2017
APA
Hong, Q., Chen, X., Ye, H., Wu, X., Wang, X., Kong, L. ... Duan, S. (2017). Chemotherapy‑induced hypomethylation of N‑myc downstream‑regulated gene 4 in the bone marrow of patients with acute myeloid leukemia. Oncology Letters, 13, 3309-3313. https://doi.org/10.3892/ol.2017.5839
MLA
Hong, Q., Chen, X., Ye, H., Wu, X., Wang, X., Kong, L., Xia, Y., Duan, S."Chemotherapy‑induced hypomethylation of N‑myc downstream‑regulated gene 4 in the bone marrow of patients with acute myeloid leukemia". Oncology Letters 13.5 (2017): 3309-3313.
Chicago
Hong, Q., Chen, X., Ye, H., Wu, X., Wang, X., Kong, L., Xia, Y., Duan, S."Chemotherapy‑induced hypomethylation of N‑myc downstream‑regulated gene 4 in the bone marrow of patients with acute myeloid leukemia". Oncology Letters 13, no. 5 (2017): 3309-3313. https://doi.org/10.3892/ol.2017.5839